# BioDelivery Sciences International trials: 21 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials with BioDelivery Sciences International as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by BioDelivery Sciences International: 21 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/biodelivery-sciences-international

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| June 25, 2019 | NCT03996694 | Single Dose Crossover Study to Compare the Respiratory Drive After Administration of Belbuca, Oxycodone and Placebo. | BioDelivery Sciences International | Phase 1 | Completed | Respiratory Depression | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03996694) |
| October 25, 2018 | NCT03720613 | Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation | BioDelivery Sciences International | Observational | Recruiting | Opioid-induced Constipation | 34,532 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03720613) |
| January 4, 2017 | NCT03009019 | Efficacy, Tolerability, and Safety of DFN-15 | BioDelivery Sciences International | Phase 3 | Completed | Migraine Headache | 631 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03009019) |
| December 30, 2016 | NCT03006276 | Efficacy, Tolerability, and Safety Study of DFN-15 | BioDelivery Sciences International | Phase 3 | Completed | Migraine Headache | 622 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03006276) |
| December 31, 2015 | NCT02643251 | The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic... | BioDelivery Sciences International | Phase 2 | Completed | Painful Diabetic Neuropathy, Diabetic Neuropathy, Neuropathy | 138 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02643251) |
| August 5, 2015 | NCT02516436 | The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects | BioDelivery Sciences International | Phase 3 | Withdrawn | Opioid Dependence | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02516436) |
| February 4, 2015 | NCT02355158 | A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy | BioDelivery Sciences International | Phase 2 | Completed | Painful Diabetic Neuropathy, Diabetes | 197 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02355158) |
| February 20, 2014 | NCT02068027 | Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy | BioDelivery Sciences International | Phase 2 | Completed | Painful Diabetic Neuropathy, Diabetic Neuropathy, Neuropathy | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02068027) |
| June 6, 2013 | NCT01871285 | Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film | BioDelivery Sciences International | Phase 2 | Completed | Pain | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01871285) |
| December 24, 2012 | NCT01755546 | Long-term Open-Label Safety Study to Evaluate EN3409 | BioDelivery Sciences International | Phase 3 | Completed | Low Back Pain, Osteoarthritis, Neuropathic Pain | 304 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01755546) |
| October 25, 2012 | NCT01713803 | Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects | BioDelivery Sciences International | Phase 3 | Withdrawn | Opioid Dependence | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01713803) |
| August 29, 2012 | NCT01675167 | Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects | BioDelivery Sciences International | Phase 3 | Completed | Low Back Pain | 815 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01675167) |
| August 16, 2012 | NCT01666119 | An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects | BioDelivery Sciences International | Phase 2 | Completed | Opioid Dependence | 249 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01666119) |
| July 6, 2012 | NCT01633944 | Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects | BioDelivery Sciences International | Phase 3 | Completed | Low Back Pain | 752 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01633944) |
| September 12, 2011 | NCT01431742 | Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Low Back Pain | BioDelivery Sciences International | Phase 3 | Withdrawn | Pain, Low Back Pain | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01431742) |
| February 18, 2011 | NCT01298765 | Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain | BioDelivery Sciences International | Phase 3 | Completed | Pain, Low Back Pain, Osteoarthritis, Neuropathic Pain | 302 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01298765) |
| December 8, 2010 | NCT01256450 | Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain | BioDelivery Sciences International | Phase 3 | Completed | Pain, Low Back Pain | 334 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01256450) |
| July 17, 2009 | NCT00941304 | Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain | BioDelivery Sciences International | Phase 2 | Completed | Dental Pain | 153 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00941304) |
| June 12, 2008 | NCT00696137 | Long-term Extension Study of BEMA™ Fentanyl | BioDelivery Sciences International | Phase 3 | Completed | Respiratory Depression | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00696137) |
| February 17, 2006 | NCT00293033 | Study of BEMA™ Fentanyl in the Treatment of Breakthrough Pain in Cancer Subjects | BioDelivery Sciences International | Phase 3 | Completed | Pain, Cancer | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00293033) |
| February 17, 2006 | NCT00293020 | Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy | BioDelivery Sciences International | Phase 3 | Completed | Pain, Cancer | 244 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00293020) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Phase 2 | 6 |
| Phase 3 | 13 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 17 |
| Withdrawn | 3 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Pain | 9 |
| Low Back Pain | 6 |
| Chronic Pain | 5 |
| Back Pain | 4 |
| Opioid-Related Disorders | 3 |
| Diabetic Neuropathies | 3 |
| Diabetes Mellitus | 3 |
| Osteoarthritis | 2 |
| Neuralgia | 2 |
| Behavior, Addictive | 2 |
| Migraine Disorders | 2 |
| Neoplasms | 2 |
| Respiratory Insufficiency | 2 |
| Neuropathy, Painful | 1 |
| Ataxia Telangiectasia | 1 |
| Toothache | 1 |
| Opioid-Induced Constipation | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Auto insurance agencies in the United States](https://specstream.ai/data/businesses/auto-insurance-agencies/united-states)
- [Internet service providers in the United States](https://specstream.ai/data/businesses/internet-service-providers/united-states)
- [Web hosting companies in the United States](https://specstream.ai/data/businesses/web-hosting-companies/united-states)
- [Greek restaurants in the United States](https://specstream.ai/data/businesses/greek-restaurants/united-states)
- [Telephone service providers in the United States](https://specstream.ai/data/businesses/telephone-service-providers/united-states)
- [Event technology companies in the United States](https://specstream.ai/data/businesses/event-technology-companies/united-states)
